Adial Pharmaceuticals (ADIL) Misses Q3 EPS by 8c

Adial Pharmaceuticals (NASDAQ: ADIL) reported Q3 EPS of ($0.08).

For earnings history and earnings-related data on Adial Pharmaceuticals (ADIL) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Nomura/Instinet Downgrades Vipshop Holdings (VIPS) to Neutral
• Erste Group Upgrades Shell Plc. (SHEL) to Buy